Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-surgical therapy for ulcerative colitis]

H Asakura1, K Suzuki, T Honma

  • 13rd Department of Internal Medicine, School of Medicine, Niigata University, Japan.

Nihon Geka Gakkai Zasshi
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use.

Clinical and experimental obstetrics & gynecology·2018
Same author

Effect of climatic elements on Campylobacter colonization in broiler flocks reared in southern Japan from 2008 to 2012.

Poultry science·2016
Same author

Continued widespread dissemination and increased poultry host fitness of Campylobacter jejuni ST-4526 and ST-4253 in Japan.

Journal of applied microbiology·2013
Same author

A case of acquired FXIII deficiency with severe bleeding symptoms.

Haemophilia : the official journal of the World Federation of Hemophilia·2012
Same author

Prevalence and growth kinetics of Shiga toxin-producing Escherichia coli (STEC) in bovine offal products in Japan.

Epidemiology and infection·2011
Same author

Lectins for Detection of Altered Glycosylation of Circulating Glycoproteins : α-1-Antitrypsin.

Methods in molecular medicine·2011

Ulcerative colitis is an inflammatory colon disease driven by immune cells producing inflammatory molecules. Treatments range from standard medications to advanced therapies like apheresis and cytokine inhibitors.

Area of Science:

  • Gastroenterology
  • Immunology
  • Inflammation Research

Context:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon and rectum's mucosa.
  • Immune cells like lymphocytes, macrophages, and neutrophils infiltrate the inflamed mucosa in UC.
  • These cells release pro-inflammatory mediators, including cytokines (e.g., IL-1, IL-6, TNF alpha) and other activators, leading to chronic inflammation.

Purpose:

  • To outline the pathophysiology of ulcerative colitis.
  • To review current and emerging non-surgical therapeutic strategies for ulcerative colitis.

Summary:

  • The disease involves immune cell infiltration and the release of inflammatory mediators in the colonic and rectal mucosa.
  • Standard treatments include aminosalicylates, corticosteroids, and immunosuppressants.

Related Experiment Videos

  • Novel therapies encompass leukocytapheresis, granulocytapheresis, anti-cytokine treatments (anti-TNF alpha, IL-1ra, IL-10), immunoglobulin therapy, and nicotine patches.
  • Impact:

    • Provides a comprehensive overview of ulcerative colitis pathogenesis and treatment options.
    • Highlights the evolution of therapeutic approaches for managing this inflammatory condition.
    • Informs clinicians and researchers about the diverse range of interventions available for ulcerative colitis.